Additionally, we are proud to have Fáilte Ireland as our official conference partner.
MeiraGTx is a Silver Sponsor of our event:
MeiraGTx is a clinical-stage gene therapy company focused on developing potentially curative treatments for patients living with serious diseases. They currently have six programs in clinical development including four ocular indications, a salivary gland condition, and a Parkinson’s disease program. Their initial focus on diseases of the eye, salivary gland and central nervous system is based on the significant unmet medical need coupled with the high potential gene therapy has to provide meaningful clinical benefit in these areas. With headquarters in New York and London, their global footprint provides them the opportunity to partner with leading institutions around the world, allowing them to deepen their understanding of diseases and their progression.
Fountain Healthcare Partners is a Bronze+ Sponsor of our event:
Fountain Healthcare Partners is a venture fund providing risk capital and expertise to ambitious entrepreneurs building outstanding life sciences companies with offices in Dublin, and New York. Founded in 2008, Fountain is Ireland’s largest dedicated life science venture capital fund with more than €294 million under management. Fountain invests in entrepreneurs and companies with disruptive technologies or products that have a clear pharmacoeconomic benefit and a defined pathway to commercialisation, value enhancement and exit.
Fáilte Ireland is our official conference partner.
Their support adds immense value to the event, and we look forward to a collaborative and impactful RIWC!
Learn more about the programme and agenda here.
General registration will soon open up and we look forward to Targeting the Cure in Dublin, this June 5-8 at the Dublin Royal Convention Centre.